Definitely an underappreciated #irAE - worth thinking about when educating about the risks of immunotherapy or if VTE occurs in the context of other irAE. Impactful work from @ta_sussman 👏
Our @DanaFarber own physician-scientists Drs. Cathy Wu & Patrick Ott were recognized by @statnews
as two of the leading cancer researchers in the world for their work in developing personalized cancer vaccines with trials conducted @DanaFarber
https://t.co/r9bzL0YUeZ
Today my great grandmother, Lily Ebert, an Auschwitz survivor, turns 99!
“I never thought I would survive Auschwitz and have another birthday. At 99, I celebrate to show that the Nazis did not win!”
All #HappyBirthdayLily wishes and comments will be passed on to Lily. ❤️
Incredible achievement positive Phase 3 trial with TIL congrats @HaanenJohn & colleagues @NKI. Game changer/new era to improve patient outcomes. FDA approval never too soon! Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma | NEJM https://t.co/mTjCqwGp5v
#ESMO2022 Melanoma Session- Prof. Dirk Schaddendorf presenting OS benefit from adjuvant high dose ipi (3) + nivo (1) in resected/radiated Stage IV melanoma - IMMUNED study now published in @TheLancet. Impressive outcome including some patients with Brain Mets post-SRS
JUST IN: For the 22nd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by @USNewsHealth!
And photos from few min ago while coming to work !
@DanaFarber@TheJimmyFund@DanaFarber_GU
https://t.co/fG9zg5WbxF